These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14565653)

  • 1. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Cassileth PA; Andersen JW; Bennett JM; Hoagland HC; Mazza JJ; O'Connell MC; Paietta E; Wiernik P
    Leukemia; 1992; 6 Suppl 2():178-81. PubMed ID: 1578927
    [No Abstract]   [Full Text] [Related]  

  • 3. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 4. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
    Longo DL; DeVita VT; Duffey PL; Wesley MN; Ihde DC; Hubbard SM; Gilliom M; Jaffe ES; Cossman J; Fisher RI
    J Clin Oncol; 1991 Jan; 9(1):25-38. PubMed ID: 1702144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    McMaster ML; Greer JP; Wolff SN; Johnson DH; Greco FA; Stein RS; Cousar JB; Flexner JM; Hainsworth JD
    Cancer; 1991 Jul; 68(2):233-41. PubMed ID: 1712662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.
    Vogler WR; Velez-Garcia E; Weiner RS; Flaum MA; Bartolucci AA; Omura GA; Gerber MC; Banks PL
    J Clin Oncol; 1992 Jul; 10(7):1103-11. PubMed ID: 1607916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B.
    Dillman RO; Davis RB; Green MR; Weiss RB; Gottlieb AJ; Caplan S; Kopel S; Preisler H; McIntyre OR; Schiffer C
    Blood; 1991 Nov; 78(10):2520-6. PubMed ID: 1824249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
    Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
    Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute lymphoblastic leukaemia (ALL).
    Jacobs P; Wood L
    Eur J Haematol; 1992 Aug; 49(2):53-8. PubMed ID: 1397240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
    Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
    Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):139-42, 187. PubMed ID: 1395923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
    Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
    Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive retreatment of adults and children with acute lymphoblastic leukemia.
    Bassan R; Cornelli PE; Battista R; Terzi F; Buelli M; Rambaldi A; Viero P; D'Emilio A; Dini E; Barbui T
    Hematol Oncol; 1992; 10(2):105-10. PubMed ID: 1592360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed or refractory adult acute lymphocytic leukemia.
    Freund M; Diedrich H; Ganser A; Gramatzki M; Heil G; Heyll A; Henke M; Hiddemann W; Haas R; Kuse R
    Cancer; 1992 Feb; 69(3):709-16. PubMed ID: 1730121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study.
    Sullivan MP; Brecher M; Ramirez I; Ragab A; Hvizdala E; Pullen J; Shuster J; Berard C; Crist W; Vietti T
    Am J Pediatr Hematol Oncol; 1991; 13(3):288-95. PubMed ID: 1793154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.
    Winick NJ; Bowman WP; Kamen BA; Roach ES; Rollins N; Jacaruso D; Buchanan GR
    J Natl Cancer Inst; 1992 Feb; 84(4):252-6. PubMed ID: 1734087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin.
    Coltman CA; Bodey GP; Hewlett JS; Haut A; Bickers J; Balcerzak SP; Costanzi JJ; Freireich EJ; McCredie KB; Groppe C; Smith TL; Gehan EA
    Arch Intern Med; 1978 Sep; 138(9):1342-8. PubMed ID: 686922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia.
    Wiernik PH; Glidewell OJ; Hoagland HC; Brunner KW; Spurr CL; Cuttner J; Silver RT; Carey RW; DelDuca V; Kung FH; Holland JF
    Med Pediatr Oncol; 1979; 6(3):261-77. PubMed ID: 381887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study.
    Mandelli F; De Lipsis E; Grignani F; Martelli M; Liso V; Amadori S
    Med Pediatr Oncol; 1978; 4(3):231-40. PubMed ID: 277749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late intensification therapy in adult acute lymphoid leukemia. The Southeastern Cancer Study Group Experience.
    Martelo OJ; Omura GA; Gordon DS; Raney M; Bartolucci AA; Vogler WR
    Am J Clin Oncol; 1992 Feb; 15(1):61-8. PubMed ID: 1550081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.